Literature DB >> 7609537

A tailored approach to antireflux surgery.

W K Kauer1, J H Peters, T R DeMeester, J Heimbucher, A P Ireland, C G Bremner.   

Abstract

Tailored surgical antireflux procedures were done in 104 patients during a 7-year period. Presenting symptoms included heartburn in 95 patients (91%), regurgitation in 83 patients (80%), and dysphagia in 61 patients (60%). Evaluation before operation included video barium esophagography, endoscopy, 24-hour esophageal pH monitoring, and esophageal motility studies. On the basis of anatomic and functional findings, the following procedures were performed: 15 laparoscopic and 49 open transabdominal Nissen fundoplications, 23 transthoracic Nissen fundoplications, seven Belsey partial fundoplications, and 10 Collis gastroplasty and Belsey partial fundoplications. The severity of symptoms was assessed before and after operation according to a previously published grading score. Eighty-five of the 104 patients (82%) were able to be contacted for a follow-up evaluation by means of a standardized questionnaire. Median length of follow-up was 4 years, with 40 patients having follow-up beyond 5 years. The tailored operation cured the symptoms of heartburn in 97%, regurgitation in 91%, and dysphagia in 92%. Ninety-eight percent of the patients reported that operation had cured their preoperative symptoms and 93% were satisfied with the outcome of the operation. To obtain optimal results, surgical treatment of gastroesophageal reflux disease should be tailored to the patient's anatomic and functional assessments. For early, uncomplicated disease a transabdominal Nissen fundoplication is done, laparoscopically when expertise exists. Patients with complicated disease should undergo an open antireflux procedure tailored to specific anatomic or functional abnormalities.

Entities:  

Mesh:

Year:  1995        PMID: 7609537     DOI: 10.1016/S0022-5223(05)80019-4

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  30 in total

1.  The changing face of treatment for hiatus hernia and gastro-oesophageal reflux.

Authors:  D I Watson; P G Devitt; G G Jamieson
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

2.  Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.

Authors:  G M Campos; J H Peters; T R DeMeester; S Oberg; P F Crookes; S Tan; S R DeMeester; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

Review 3.  Surgery for hiatal hernia and GERD. Time for reappraisal and a balanced approach ?

Authors:  D E Low
Journal:  Surg Endosc       Date:  2001-06-19       Impact factor: 4.584

Review 4.  Complications of laparoscopic antireflux surgery.

Authors:  D I Watson; A C de Beaux
Journal:  Surg Endosc       Date:  2001-02-06       Impact factor: 4.584

5.  Experimental antireflux surgery.

Authors:  K A Gawad; C Bloechle; T Strate; J R Izbicki
Journal:  Surg Endosc       Date:  1999-06       Impact factor: 4.584

6.  [Laparoscopic fundoplication. Indications and results].

Authors:  K H Fuchs; H Feussner
Journal:  Internist (Berl)       Date:  2003-01       Impact factor: 0.743

7.  Severely disordered esophageal peristalsis is not a contraindication to laparoscopic Nissen fundoplication.

Authors:  Y W Novitsky; J Wong; K W Kercher; D E M Litwin; L L Swanstrom; B T Heniford
Journal:  Surg Endosc       Date:  2006-12-20       Impact factor: 4.584

Review 8.  Patient assessment of treatment satisfaction: methods and practical issues.

Authors:  D A Revicki
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 9.  Evidence-based appraisal of antireflux fundoplication.

Authors:  Marco Catarci; Paolo Gentileschi; Claudio Papi; Alessandro Carrara; Renato Marrese; Achille Lucio Gaspari; Giovanni Battista Grassi
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

10.  Can different subsets of ineffective esophageal motility influence the outcome of nissen fundoplication?

Authors:  Aleksandar P Simić; Ognjan M Skrobić; Richard R Gurski; Vladimir M Šljukić; Nenad R Ivanović; Predrag M Peško
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.